Healthcare Phase 2 trial of Oxford COVID-19 vaccine candidate set to begin from Tuesday Updated : August 25, 2020 07:35 AM IST Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford. The trials are to be conducted across 17 selected sites. Around 1,600 people aged above 18 years are likely to participate in the trials. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.